{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T08:37:03Z","timestamp":1717490223047},"reference-count":28,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3960\/jslrt.54.155","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T23:26:30Z","timestamp":1413329190000},"page":"155-161","source":"Crossref","is-referenced-by-count":3,"title":["CD5- and CD23-Positive Splenic Diffuse Large B-Cell Lymphoma with Very Low CD20 Expression"],"prefix":"10.3960","volume":"54","author":[{"given":"Rie","family":"Tabata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Yasumizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Shimizu-Kohno K, Kimura Y, Kiyasu J, Miyoshi H, Yoshida M, <I>et al<\/I>.: Malignant lymphoma of the spleen in Japan: a clinicopathological analysis of 115 cases. Pathol Int 62:577-582, 2012"},{"key":"2","unstructured":"2 Mollejo M, Algara P, Mateo MS, Men&aacute;rguez J, Pascual E, <I>et al<\/I>.: Large B-cell lymphoma presenting in the spleen: identification of different clinicopathologic conditions. Am J Surg Pathol 27:895-902, 2003"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Kashimura M, Noro M, Akikusa B, Okuhara A, Momose S, <I>et al<\/I>.: Primary splenic diffuse large B-cell lymphoma manifesting in red pulp. Virchows Arch 453:501-509, 2008","DOI":"10.1007\/s00428-008-0673-y"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Kroft SH, Howard MS, Picker LJ, Ansari MQ, Aquino DB, <I>et al<\/I>.: <I>De novo<\/I> CD5<SUP>+<\/SUP> diffuse large B-cell lymphomas. A heterogeneous group containing an unusual form of splenic lymphoma. Am J Clin Pathol 114:523-533, 2000","DOI":"10.1309\/RM1Q-1T0B-WKQB-AF5A"},{"key":"5","unstructured":"5 Dufresne SD, Felgar RE, Sargent RL, Surti U, Gollin SM, <I>et al<\/I>.: Defining the borders of splenic marginal zone lymphoma: a multiparameter study. Hum Pathol 41:540-551, 2010"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kwon MS, Go JH, Choi JS, Lee SS, Ko YH, <I>et al<\/I>.: Critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the stomach and small intestine. Am J Surg Pathol 27:790-798, 2003","DOI":"10.1097\/00000478-200306000-00010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Lai R, Weiss LM, Chang KL, Arber DA: Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43<SUP>+<\/SUP> follicular lymphomas. Am J Clin Pathol 111:488-494, 1999","DOI":"10.1093\/ajcp\/111.4.488"},{"key":"8","unstructured":"8 Yamaguchi M, Nakamura N, Suzuki R, Kagami Y, Okamoto M, <I>et al<\/I>.: <I>De novo<\/I> CD5<SUP>+<\/SUP> diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients. Haematologica 93:1195-1202, 2008"},{"key":"9","unstructured":"9 Matolcsy A, Chadburn A, Knowles DM: <I>De novo<\/I> CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am J Pathol 147:207-216, 1995"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Nera KP, Kohonen P, Narvi E, Peippo A, Mustonen L, <I>et al<\/I>.: Loss of Pax5 promotes plasma cell differentiation. Immunity 24:283-293, 2006","DOI":"10.1016\/j.immuni.2006.02.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Nera KP, Lassila O: Pax5 - A critical inhibitor of plasma cell fate. Scand J Immunol 64:190-199, 2006","DOI":"10.1111\/j.1365-3083.2006.01809.x"},{"key":"12","unstructured":"12 McCune RC, Syrbu SI, Vasef MA: Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB. 1, and PU. 1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays. Mod Pathol 19:1010-1018, 2006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Chu PG, Loera S, Huang Q, Weiss LM: Lineage determination of CD20- B-cell neoplasms: an immunohistochemical study. Am J Clin Pathol 126:534-544, 2006","DOI":"10.1309\/3WG32YRAMQ7RB9D4"},{"key":"14","unstructured":"14 Johnson NA, Boyle M, Bashashati A, Leach S, Brooks-Wilson A, <I>et al<\/I>.: Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival. Blood 113:3773-3780, 2009"},{"key":"15","unstructured":"15 Li YJ, Li ZM, Rao HL, Xia Y, Huang HQ, <I>et al<\/I>.: CD20-negative <I>de novo<\/I> diffuse large B-cell lymphoma in HIV-negative patients: a matched case-control analysis in a single institution. J Transl Med 10:84, 2012"},{"key":"16","unstructured":"16 Tokunaga T, Tomita A, Sugimoto K, Shimada K, Iriyama C, <I>et al<\/I>.: <I>De novo<\/I> diffuse large B-cell lymphoma with a CD20 immunohistochemistry-positive and flow cytometry-negative phenotype: Molecular mechanisms and correlation with rituximab sensitivity. Cancer Sci 105:35-43, 2014"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Bonnefoy JY, Lecoanet-Henchoz S, Gauchat JF, Graber P, Aubry JP, <I>et al<\/I>.: Structure and functions of CD23. Int Rev Immunol 16:113-128, 1997","DOI":"10.3109\/08830189709045705"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Garcia DP, Rooney MT, Ahmad E, Davis BH: Diagnostic usefulness of CD23 and FMC-7 antigen expression patterns in B-cell lymphoma classification. Am J Clin Pathol 115:258-265, 2001","DOI":"10.1309\/VWTK-XYT5-D0DK-06HQ"},{"key":"19","unstructured":"19 Linderoth J, Jerkeman M, Cavallin-St&#xE5;hl E, Kval&oslash;y S, Torlakovic E: Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: A Nordic Lymphoma Group Study. Clin Cancer Res 9:722-728, 2003"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Calaminici M, Piper K, Lee AM, Norton AJ: CD23 expression in mediastinal large B-cell lymphomas. Histopathology 45:619-624, 2004","DOI":"10.1111\/j.1365-2559.2004.01969.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Taniguchi M, Oka K, Hiasa A, Yamaguchi M, Ohno T, <I>et al<\/I>.: <I>De novo<\/I> CD5<SUP>+<\/SUP> diffuse large B-cell lymphomas express VH genes with somatic mutation. Blood 91:1145-1151, 1998","DOI":"10.1182\/blood.V91.4.1145"},{"key":"22","unstructured":"22 Zhang X, Sun M, Zhang L, Shao H: Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review. Int J Clin Exp Pathol 6:985-989, 2013"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Prevodnik VK, Lavren&#x10D;ak J, Horvat M, Novakovi&#x10D; BJ: The predictive significance of CD20 expression in B-cell lymphomas. Diagn Pathol 6:33, 2011","DOI":"10.1186\/1746-1596-6-33"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Nakamura N, Abe M: Richter syndrome in B-cell chronic lymphocytic leukemia. Pathol Int 53:195-203, 2003","DOI":"10.1046\/j.1320-5463.2003.01455.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Tsimberidou AM, Keating MJ: Richter syndrome: Biology, incidence, and therapeutic strategies. Cancer 103:216-228, 2005","DOI":"10.1002\/cncr.20773"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Rossi D, Gaidano G: Richter syndrome: molecular insights and clinical perspectives. Hematol Oncol 27:1-10, 2009","DOI":"10.1002\/hon.880"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Molica S: A systematic review on Richter syndrome: what is the published evidence ? Leuk Lymphoma 51:415-421, 2010","DOI":"10.3109\/10428190903515192"},{"key":"28","unstructured":"28 Mao Z, Quintanilla-Martinez L, Raffeld M, Richter M, Krugmann J, <I>et al<\/I>.: IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am J Surg Pathol 31:1605-1614, 2007"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:44Z","timestamp":1621540004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/54\/2\/54_155\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.54.155","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}